Retatrutide differs from other weight-loss peptides like semaglutide because it targets multiple hormone receptors, not just GLP-1
There is little information on the interactions between GLP-1 agonists and biologics, though at present, it does not appear that GLP-1 agonists have any direct negative effects on biologics
Fortunately, GLP-1RAs seem to have the potential to become a multi-target medicine
HUBERMAN: And this is very important to understand because unlike a lot of our discussion on this podcast about dopamine or about specific hormones like testosterone or estrogen, when we talk about peptides, especially therapeutic peptides, oftentimes we're talking about a single peptide that does a bunch of different things depending on the cell type, the time of day or night that that peptide is present, and even the different so-called downstream effects of the peptide
Direct questions, active listening with empathy and signposting to specialist services are all key skills for physiotherapists and highly valued by women with musculoskeletal pain and menopausal symptoms
No pattern of undelivered medications, unauthorized charges, or identity theft emerges from the broader review pool